Susanne Petri
Susanne Petri
Professorin für Neurologie, Medizinische Hochschule Hannover
Verifierad e-postadress på mh-hannover.de
Titel
Citeras av
Citeras av
År
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
KP Lesch, D Bengel, A Heils, SZ Sabol, BD Greenberg, S Petri, ...
Science 274 (5292), 1527-1531, 1996
60281996
Allelic variation of human serotonin transporter gene expression
A Heils, A Teufel, S Petri, G Stöber, P Riederer, D Bengel, KP Lesch
Journal of neurochemistry 66 (6), 2621-2624, 1996
25901996
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:
European journal of neurology 19 (3), 360-375, 2012
6712012
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ...
Nature genetics 48 (9), 1043-1048, 2016
3302016
Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene
A Heils, A Teufel, S Petri, M Seemann, D Bengel, U Balling, P Riederer, ...
Journal of Neural Transmission/General Section JNT 102 (3), 247-254, 1995
3091995
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
AC Ludolph, C Bendotti, E Blaugrund, A Chio, L Greensmith, JP Loeffler, ...
Amyotrophic Lateral Sclerosis 11 (1-2), 38-45, 2010
2742010
Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn‐superoxide dismutase mutant mice
M Damiano, AA Starkov, S Petri, K Kipiani, M Kiaei, M Mattiazzi, ...
Journal of neurochemistry 96 (5), 1349-1361, 2006
2642006
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways
V Swarup, D Phaneuf, N Dupré, S Petri, M Strong, J Kriz, JP Julien
Journal of Experimental Medicine 208 (12), 2429-2447, 2011
2452011
ALSFRS-R score and its ratio: a useful predictor for ALS-progression
K Kollewe, U Mauss, K Krampfl, S Petri, R Dengler, B Mohammadi
Journal of the neurological sciences 275 (1-2), 69-73, 2008
2092008
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
M Graf, D Ecker, R Horowski, B Kramer, P Riederer, M Gerlach, C Hager, ...
Journal of neural transmission 112 (5), 649-660, 2005
1972005
Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei, K Kipiani, S Petri, J Chen, NY Calingasan, MF Beal
Neurodegenerative Diseases 2 (5), 246-254, 2005
1952005
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis
M Kiaei, S Petri, K Kipiani, G Gardian, DK Choi, J Chen, NY Calingasan, ...
Journal of Neuroscience 26 (9), 2467-2473, 2006
1882006
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis
S Petri, M Kiaei, K Kipiani, J Chen, NY Calingasan, JP Crow, MF Beal
Neurobiology of disease 22 (1), 40-49, 2006
1762006
Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
A Neymotin, NY Calingasan, E Wille, N Naseri, S Petri, M Damiano, ...
Free Radical Biology and Medicine 51 (1), 88-96, 2011
1692011
Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis
S Petri, M Kiaei, M Damiano, A Hiller, E Wille, G Manfredi, NY Calingasan, ...
Journal of neurochemistry 98 (4), 1141-1148, 2006
1602006
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ...
The Lancet Neurology 17 (5), 423-433, 2018
1522018
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients
W Guo, M Naujock, L Fumagalli, T Vandoorne, P Baatsen, R Boon, ...
Nature communications 8 (1), 1-15, 2017
1372017
Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS
S Petri, S Körner, M Kiaei
Neurology research international 2012, 2012
1372012
Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis
A Sarlette, K Krampfl, C Grothe, N Neuhoff, R Dengler, S Petri
Journal of Neuropathology & Experimental Neurology 67 (11), 1055-1062, 2008
1232008
Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation
M Naumann, A Pal, A Goswami, X Lojewski, J Japtok, A Vehlow, ...
Nature communications 9 (1), 1-17, 2018
1082018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20